Presentation on theme: "Dr. Savas ALPAY Director General Dr. Savas ALPAY Director General Real Progress Shared Progress."— Presentation transcript:
Dr. Savas ALPAY Director General Dr. Savas ALPAY Director General Real Progress Shared Progress
Statistical Economic and Social Research and Training Centre for Islamic Countries (SESRTCIC) A subsidiary organ of the Organization of the Islamic Conference (OIC) The OIC was established in 1969 It has now 57 member countries It is the 2nd largest International Organization after the UN 27 members in Africa, 26 in Asia, 2 in Europe and 2 in south America
World Forum Fostering the development of evidence-based public choice and facts-based civic dialogue. Improving the effectiveness of indicator work and their use for policy making. Fostering a global conversation about what progress actually means. ** OECD World Forum is an important undertaking.
Ensuring its Success A Carefully Designed Action Plan Encompassing All Stakeholders Desired Targets be strategically chosen and transperancy be embedded throughout the Forum road map Enthusiasm, excitement and support from developing countries essential
Progress ? National or Global? How to separate and combine? Can one talk about Progress at the national level in the presence of global failures: Climate change Global warming Ozone layer depletion Child labor explotation
Progress ? Generations bequesting their descendants a more lively place to live, not new problems. What kind of progress are we talking about if future generations will have problems in even breathing clean air, and will have difficulty in access to clean drinking water!
Progress ? Equity Dimension ? (Inter-generational and Intra-generational) Incorporation of Externalities? (Is it acceptable to see natural resources as commodities and price them accordingly?)
Progress Shared ? As pointed out in the report of the UN Secretary General to the Millennium Assembly of the United Nations (2000), each state has a dual role in the global world, and this duality recognizes that each state not only bears responsibilities in relation to its own people but also collectively shares responsibility for the whole planet. Therefore, defining Real Progress is not an easy task as it may appear.
Progress ? Given the uneasiness for the use of GDP as a measure of progress, new alternatives have been sought [ Index of Sustainable Economic Welfare (ISEW) ]. As briefly touched upon, measuring progress requires a comprehensive approach. Millennium Development Goals is an attempt in the right direction !
Millennium Development Goals Requires a strong statistical database to identify whether the goals are being reached by the respective deadlines. The quest for reaching MDGs most notably showed that many developing countries need to start measuring a number of indicators: there is a significant data gap !
Economists have come to feel What cant be measured, isnt real. The truth is always an amount Count numbers, only numbers count. (Chambers 1997)
Better Statistics, Better Policy There is a strong need for Statistical Capacity Building Global imbalance in the capacity to build strong statistical infrastructure across the Developed and Developing Countries The potential for closing the gap in the near future ?
Global Imbalances One of the most prevelant gaps between developed and developing world is the current stance of Science and Technology in these countries. In fact, it can even be reasonably argued that almost all gaps between developed and developing world can be narrowed down by developing, managing and properly applying appropriate knowledge. It is almost impossible for any country to achieve and sustain prosperity and a high quality of life without ensuring a strong scientific infrastructure and a well- educated population. An important aspect and determinant of progress: Transition to knowledge-based economies and societies.
World GDP, Population, and R&D Expenditure and Personnel
Share of World Gross Expenditure on R&D, (2000)
Shares of World GERD, (Source: UIS 2003 estimates)
R&D Personnel in (Source UIS Estimates 2003)
Innovation Capacity Not only current stance of research and development (R&D) activities results in huge differences in the current prosperity of nations, but also it has big impact on their future achievements. Innovation capacity and so the potential to develop new technologies immensely differs across nations, and it is not easy to determine the ways to make this process more equitable.
NANOTECHNOLOGY INVESTMENTS Total Investment (world) in 2005: 6 Billion USD European Union: 4.8 Billion Euro for 7 th Framework Projects South Africa: 170 million USD for next 3 years Israel: 230 million USD for next 5 years National Cancer Institute (USA): 143 million USD for next 5 years
Nanotechnology: Truly Outstanding Possibilities Enabling the blind to see, the lame to walk, and the deaf to hear; Curing and preventing AIDS, cancer, diabetes and other afflictions; Ending hunger; Providing clean, renewable, affordable energy; Extending the length and the quality of life through the repair- and eventually even the replacement-of failing organs Repairing existing environmental damage; Nanocomputers smaller than a bacterium; Data storage devices with memory densities sufficient to store the entire collection of the Library of Congress on a device the size of a sugar cube; Materials up to 100 times stronger than steel, at a fraction of the weight
Nanotechnology: Economical Impact Production cost < 10$ Selling Price: $ Total income in 2004: 3 Billion $ Total income in 2007 (expected): 11 Billion$ Largest local income item around Boston area (USA) Heart Stent Nanotechnology Will Have Very Big Impact On Economy Global market for nano products could reach $1 trillion by Many countries including USA, Germany, Israel, Korea support nanotechnology research as a critical field due to huge economical impacts. In Israel, 45 nanotechnology companies have already started to selling nano-products. China started a program to educate 1 million scientist and engineers in nanotechnology related fields. China expects to get very big economical impact from their nanotechnology investments.
Nanobiotechnology: Treatment of Cancer CpG ODN: DNA Nano capsul < 100nm Days Tumor Size (mm 2 ) IL-13 toxin + (CpG ODN) Lipo IL-13 toxin control Scientist observed that 91% of mice are free of tumor after this treatment.
Under the circumstances, one can think of a new role for statisticians in monitoring the trends to identify new technological developments and new revolutionary waves (with supporting evidences from pertinent information) and channel this to decision- makers in a timely manner: A non-conventional task for the statistician !